In addition to PRLT, we also offer the entire spectrum of nuclear medicine therapies:

  • Radioiodine therapy for benign and malignant thyroid diseases
  • Peptide Receptor Radionuclide Therapy (PRRT) for patients with neuroendocrine tumors
  • Selective Internal Radiotherapy (SIRT) of liver metastases / tumors
  • RSO (radiosynoviorthesis) for inflammatory joint diseases
  • Palliative pain therapy with Sm-153 EDTMP as well as with Lu-177 Zoledronate
  • Radio-immunotherapy with Zevalin for lymphoma
  • I-131 MIBG therapy for neuroblastoma and metastatic pheochromocytoma